4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-020160
CEO sold 2,253 shares at $6.45 ($14,523)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shah Gaurav CEO | 2025-05-20 | Sale | −2,253 | $6.45 | $14,523 | 786,806 | D: show line 1 in the form |
| Open-market sales · 2,253 sh · avg $6.45 · $14,523 | |||||||
Loading xslF345X05/form4.xml…